[1] TAKⅡ T,YASUDA S,TAKAHASHI J,et al.Trends in acute myocardial infarction incidence and mortality over 30 years in Japan:report from the MIYAGI-AMI Registry Study[J].Circ J,2010,74(1):93.
[2] MARENZI G,ASSANELLI E,CAMPODONICO J,et al.Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality[J].Ann Intern Med,2009,150(3):170.
[3] MCCULLOUGH PA.Contrast-induced acute kidney injury[J].J Am Coll Cardiol,2008,51(15):1419.
[4] MARENZI G,ASSANELLI E,MARANA I,et al.N-acetylcysteine and contrast-induced nephropathy in primary angioplasty[J].N Engl J Med,2006,354(26):2773.
[5] CHO JY,JEONG MH,HWAN PARK S,et al.Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure[J].J Cardiol,2010,56(3):300.
[6] WATABE H,SATO A,HOSHI T,et al.Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention[J].Int J Cardiol,2014,174(1):57.
[7] MERTEN GJ,BURGESS WP,RITTASE RA,et al.Prevention of contrast-induced nephropathy with sodium bicarbonate:an evidence-based protocol[J].Crit Pathw Cardiol,2004,3(3):138.
[8] GOLDENBERG I,MATETZKY S.Nephropathy induced by contrast media:pathogenesis,risk factors and preventive strategies[J].CMAJ,2005,172(11):1461.
[9] NOZUE T,MICHISHITA I,IWAKI T,et al.Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention[J].J Cardiol,2009,54(2):214.
[10] MARENZI G,DE METRIO M,RUBINO M,et al.Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention[J].Am Heart J,2010,160(6):1170.
[11] LIU Y,TAN N,ZHOU YL,et al.High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention[J].J Nephrol,2012,25(3):332.